SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd

BlackBerry is trending as community members discuss its potential, citing bullish technical indicators and increased volume.  Optimism surrounds potential partnerships and the value of QNX technology in automotive AI, with some speculating on a possible acquisition.  The community anticipates upcoming earnings as a catalyst for further upward movement.

Pump.fun

$PUMP.X is trending as discussions revolve around its potential as a platform and its association with meme coins on Solana. The community is actively discussing its growth potential, with some anticipating significant gains. There's also excitement around live streams and community engagement.

"What's Updog?" is a Community Led token.

UpDog

$UPDOG.X is trending as the community rallies around the meme-driven coin built on Solana, asking 'What's Updog?' and highlighting its presence on the Jupiter Strict List. Some are drawing comparisons to other popular dog-themed cryptocurrencies, while others are focused on loading up and pushing for new highs. The community emphasizes its long-term development and charitable aspects.

Orderly Network is a L2 built on OP stack delivering a permissionless liquidity layer for Web3 trading, with one shared orderbook across different blockchains — powered by Orderly Chain and LayerZero. Our mission is to empower trading on any chain, any asset, any interface. Orderly offers spot and perpetual futures orderbooks trading across Arbitrum, Optimism, Polygon, Base ,Mantle and Near, while expanding to other blockchains.

Orderly Network

Orderly Network's crypto, $ORDER.X, is gaining attention, sparking community excitement about its potential. The community is actively discussing its prospects alongside other cryptocurrencies, speculating on potential growth. Some users are indicating they are accumulating the token.

Uranus DEX is an innovative decentralized exchange (DEX) built on the Solana blockchain, designed as a permissionless, player-versus-player (PvP) prediction market platform. Unlike traditional DEXs that rely on automated market makers (AMMs) or liquidity pools, Uranus DEX offers a unique model where users can make long or short predictions on the price movements of any Solana-based token, including real-world assets (RWAs). This community-driven platform enables traders to engage directly from their crypto wallets, creating a transparent and accessible trading experience.  Built on Solana’s high-throughput, low-cost blockchain, Uranus DEX delivers fast transactions with minimal fees, appealing to both novice and seasoned traders. Its permissionless design allows users to speculate on any listed Solana token without restrictions, fostering a competitive PvP environment for price predictions. This flexibility empowers users to engage in dynamic trading battles, making it a standout in the decentralized finance (DeFi) space.  The native token, $URA, is integral to the ecosystem, supporting staking, governance, and community rewards. Trading fees are used to buy and vault $URA tokens, which are then allocated to liquidity events, ensuring platform sustainability and incentivizing participation. Uranus DEX enhances user accessibility by integrating with social platforms like X, allowing seamless trading through intuitive interfaces, broadening its appeal and engagement.  The platform has gained traction in the crypto community, notably through its participation in the Bonk Hackathon and milestones like reaching 1,000 followers on X. Positioned as a first mover in PvP prediction markets, Uranus DEX aims to democratize DeFi with a scalable, user-centric approach. Its smart contracts are verifiable on Solana’s blockchain explorer, ensuring transparency and security for users.  As with any DeFi platform, users should exercise caution, verify contract addresses, and be aware of risks such as price slippage and market volatility. For more details, visit uranus.today to explore the platform’s features, tokenomics, and community initiatives. Uranus DEX redefines decentralized trading by combining Solana’s technical efficiency with a bold vision for accessible, community-driven prediction markets.

Ura is trending amid discussions about its constructive chart patterns, potential gap fill toward all-time highs, and alignment with the AI energy thesis. Bullish community members are pointing to strong closes and increasing volume, anticipating further upward movement if futures behave favorably. Mentions of Trump are also appearing alongside the trending stock.

MATH is a one stop crypto solution platform which contains MathWallet, MATH VPOS Pool, MathDEX, MATH dApp Store, MATH Staking, MATH Pay, MATH Chain, etc.

MATH

MATH.X is trending as traders discuss recent price movement and potential for future pumps, with some highlighting its low market cap and past performance. Community members are debating whether it can sustain gains or if it will be another pump and dump, while others express frustration with its price action and CEO.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is trending as the community debates potential price movements and trading strategies, with some anticipating a decline and others hoping for a breakout. Discussions revolve around identifying 'suckers' and 'greedy' traders, reflecting a speculative environment. Recent integrations like the tokenized uranium offering (xU3O8) and Ankr's Etherlink RPC are also mentioned, highlighting ongoing development within the Tezos ecosystem.

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Flora Growth Corp

FLGC is trending due to community excitement surrounding potential catalysts, including a new supply agreement and participation in German cannabis pilot programs. Conversations revolve around the company's strategy, such as its expansion into the THC-infused beverage market and integration of crypto payments, while some express concerns about dilution and past performance. The stock's low float and potential for a short squeeze are also key talking points among investors.

Anheuser-Busch InBev SA/NV operates as a holding company, which engages in the manufacture and distribution of alcoholic and non-alcoholic beverages. It operates through the following geographical segments: North America, Middle Americas, South America, EMEA, Asia Pacific, and Global Export and Holding Companies. The company was founded on August 2, 1977 and is headquartered in Leuven, Belgium.

Anheuser-Busch InBev SA/NV - ADR

Anheuser-Busch InBev

Anheuser-Busch InBev (BUD) is trending as community members discuss potential short squeeze opportunities and debate the effectiveness and impact of past boycotts on the company's stock. Some are speculating about potential marketing strategies, including celebrity endorsements, to revive the Bud Light brand, while others are analyzing recent earnings reports and volume declines in key markets.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT.X) is trending as community members highlight its recent price surge and compare it to other decentralized exchanges like $HYPE.X and $MYX.X.  Discussions revolve around potential price targets and whether it will continue its parabolic run or experience a pullback. Many are attributing the attention to backing from major players like Peter Thiel and Pantera Capital.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

All You Need to Know About Cellectar Biosciences (CLRB) Rating Upgrade to Buy

Cellectar Biosciences (CLRB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Are Medical Stocks Lagging  Anixa Biosciences (ANIX) This Year?

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies

4 Medical Product Stocks to Watch From a Challenging Industry

Strong Buy Recommendation for Cellectar Biosciences on Positive Phase 2b Results and Solid Financials

Analyst Jason McCarthy of Maxim Group maintained a Buy rating on Cellectar Biosciences (CLRB Research Report), retaining the price target of $7.0...

Buy Rating Affirmed for Cellectar Biosciences on Strong Clinical Results and Improved Financial Outlook

Analyst Jason McCarthy from Maxim Group maintained a Buy rating on Cellectar Biosciences (CLRB Research Report) and keeping the price target at...

Buy Rating on Cellectar Biosciences Backed by Promising Drug Candidate and Solid Financials

Maxim Group analyst Jason McCarthy has reiterated their bullish stance on CLRB stock, giving a Buy rating today. Jason McCarthy has given his Buy r...

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript March 27, 2024
Cellectar Biosciences, Inc. isnt one of the 30 most popular stocks among hedge funds at the end of the...

Q4 2023 Cellectar Biosciences Inc Earnings Call Transcript

Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update

Management to host a conference call today at 8:30 am ETFLORHAM PARK, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical...

Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124, which could detect tumors and metastases in a broad range of cancers, and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded on June 24, 1996 and is headquartered in Florham Park, NJ.

Cellectar Biosciences Inc

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

CLRB
Cellectar Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CLRB News

CLRB Cellectar Biosciences Inc